alexa Evaluation Of SHLA-G Levels In Serum Of Patients With Prostate Cancer As A New Potential Tumor Marker | 22748
ISSN: 1948-5956

Journal of Cancer Science & Therapy
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

4th World Congress on Cancer Science & Therapy
October 20-22, 2014 DoubleTree by Hilton Hotel Chicago-North Shore Conference Center, USA

Mohammad Hassan Heidari
Accepted Abstracts: J Cancer Sci Ther
DOI: 10.4172/1948-5956.S1.035
Abstract
Introduction: PSA level in patients with prostate cancer, is usually elevated. It has been strongly recommended that PSA is used in conjunction with other tests and examinations to enhance early detection of prostate cancer but probably that isn?t enough for Stickler Specification, sHLA-G has been considered as a new tumor marker with high sensitivity for prostate cancer diagnosis comparison PSA. This study aims at evaluating the changes in levels of serum sHLA-G biomarker in patients with prostate cancer and determining the efficacy of this biomarker for diagnosis of prostate cancer. Martial and method: This descriptive-analytical study was performed on men with prostate cancer. The serum levels of sHLA-G and PSA were measured using Electrochemiluminescence (ELISA) and proteomics techniques. The data was analyzed using SPSS Ver. 11 and the level of statistical significance was considered to be p<0.05. Totally, 120 subjects participated in this study, including 40 men patients with malignant prostate tumors, 40 men patients with benign tumors and 40 healthy men. A significant increase in serum prostate and PSA levels was observed for malignant group comparing with the control group and the people with benign tumors (p<0.05). Results: The cut-off point, sensitivity and specificity of sHLA-G in diagnosis of prostate malignancies compared with prostate benign tumors and the control group were 5.6 μg/ml, 0.19 and 0.95, respectively. These levels were reported for PSA in diagnosis of prostate malignancies prostate benign tumors and the control group as 26.18, 0.75 and 0.46 U/ml respectively. Conclusion: Probably that sHLA-G serve as a good biomarker for prostate cancer diagnosis with suitable sensitivity and specificity adjacent PSA.
image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version